Dr Kate Vandyke
Research Fellow (C) (with PhD)
School of Biomedicine
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
I am lead of the Myeloma Research Laboratory, Faculty of Health and Medical Sciences, University of Adelaide, based at the South Australian Health and Medical Research Institute (SAHMRI), Precision Medicine Theme.
My research interests involve elucidating the molecular and cellular mechanisms responsible for the disease progression in the bone marrow cancer multiple myeloma. Myeloma is the second most common blood cancer, responsible for over 100,000 deaths per year, world-wide. While significant advances in myeloma treatment over the past decade have greatly improved survival rates for multiple myeloma, almost all patients eventually relapse and succumb to their disease. My studies are primarily aimed at identifying those patients that do very poorly, surviving less than 2 years, and identifying tailored treatments for this group of patients.https://aurora.adelaide.edu.au/userprofile.html?uid=3778&em=true#
Current projects include:
- Defining major cellular and molecular mechanisms that drive tumour dissemination in multiple myeloma
- Identifying how changes to the myeloma bone marrow microenvironment drive disease progression for MGUS and smouldering myeloma to multiple myeloma
- Identification of novel serum biomarkers that enable the identification of high-risk MGUS, smouldering myeloma and multiple myeloma patients
- Using novel drug delivery strategies to increase tumour drug uptake and decrease off-target side-effects in multiple myeloma and paediatric brain cancers
- Identification of novel therapeutic targets for the treatment of high-risk multiple myeloma
PhD projects available
Using cutting-edge multiomic approaches to clinically relevant tumour vulnerabilities in multiple myeloma
To improve outcomes for multiple myeloma patients, we urgently need to identify novel pathways that contribute to myeloma development, drug resistance and relapse. Our data suggest that the growth of myeloma tumour cells is critically dependent on the expression of genes from several specific metabolic pathways, suggesting that adaptive changes in myeloma cell metabolism plays a critical role in tumour growth. In this project, CRISPR gRNA screens and metabolomics will be used to dissect the metabolic dependencies of myeloma tumours, using both patient-derived samples and cutting-edge mouse models. By pinpointing the critical metabolic pathways that fuel tumour growth, we aim to identify new, precise therapeutic targets that could revolutionise myeloma treatment.
Projects available for: PhD, Honours
Location: SAHMRI
Research project start: Semester 1 and 2
-
Appointments
Date Position Institution name 2021 - ongoing Co-lead, Myeloma Research Laboratory University of Adelaide 2020 - ongoing Senior research fellow South Australian Health and Medical Research Institute 2018 - 2021 Beat Cancer Early Career Research Fellow University of Adelaide, Adelaide 2017 - 2018 Post-doctoral Research Scientist University of Adelaide, Adelaide 2013 - 2016 Mary Overton Early Career Research Fellow SA Pathology 2012 - 2018 Affiliate Lecturer University of Adelaide 2012 - 2013 Multiple Myeloma Research Foundation Research Fellow SA Pathology 2010 - 2012 Post-doctoral Research Scientist SA Pathology 2007 - 2010 Technical assistant (part time) SA Pathology 2005 - 2006 Research Assistant Prince of Wales Hospital -
Education
Date Institution name Country Title 2007 - 2010 University of Adelaide Australia PhD 2000 - 2004 University of New South Wales Australia BMedSci (Hons) -
Research Interests
-
Journals
-
Conference Papers
Year Citation 2024 Toomes, C., McClure, B., Best, G., Ebert, L., Vandyke, K., Cockshell, M., . . . Bonder, C. (2024). Elevated Desmoglein-2 Surface Expression Is an Independent Predictor of Poor Outcome in Multiple Myeloma. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Vol. 24 (pp. S199-S200). CIG MEDIA GROUP, LP. 2023 Williams, C., Noll, J., Harnas, D., Parkinson, H., Hewett, D., Wyllie, K., . . . Panagopoulos, V. (2023). Targeted Inhibition of Myeloperoxidase (MPO): A New Therapeutic Strategy for the Treatment of Multiple Myeloma. In BLOOD Vol. 142 (pp. 3 pages). CA, San Diego: AMER SOC HEMATOLOGY.
DOI2023 Cheney, E. A. J., Harnas, D., Noll, J., Vandyke, K., Zannettino, A., & Hewett, D. (2023). Towards an IMiD sensitive C57BL/KaLwRij murine model of multiple myeloma. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Vol. 23 (pp. S135). CIG MEDIA GROUP, LP. 2017 Zeissig, M. N., Hewett, D. R., Martin, S., Mrozik, K. M., Cheong, C. M., Diamond, P., . . . Zannettino, A. C. W. (2017). HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY. 2014 Vandyke, K., Mrozik, K. M., Cheong, C. M., Chow, A. W. S., Kok, C. H., Blaschuk, O., . . . Zannettino, A. C. W. (2014). Identification of an Epithelial-to-Mesenchymal Transition (EMT)-like Programme in t(4;14)-Positive Multiple Myeloma Reveals Novel Targets for Therapeutic Intervention. In BLOOD Vol. 124 (pp. 3 pages). San Francisco, CA: AMER SOC HEMATOLOGY.
WoS12013 Noll, J., Williams, S., Vandyke, K., Kok, C., & Zannettino, A. (2013). IDENTIFICATION AND CHARACTERISATION OF THE ROLE OF SAMSN1 GENE EXPRESSION IN A MURINE MODEL OF MYELOMA AND MYELOMA PATIENTS. In HAEMATOLOGICA Vol. 98 (pp. 316). FERRATA STORTI FOUNDATION. 2008 Vandyke, K., Dewar, A., Diamond, P., Fitter, S., Farrugia, A. N., To, L. B., . . . Zannettino, A. C. W. (2008). Dasatinib (Sprycel™) Inhibits Oteoclast Activity <i>in Vitro</i> and <i>in Vivo</i> Via a C-Fms-Dependent and C-Src-Independent Mechanism. In BLOOD Vol. 112 (pp. 1102-1103). San Francisco, CA: AMER SOC HEMATOLOGY. 1992 WOODFORK, K. A., WONDERLIN, W. F., VANDYKE, K., & STROBL, J. S. (1992). THE EFFECT OF K+ CHANNEL BLOCKERS ON PROLIFERATION AND CA++-ACTIVATED K+ CURRENTS IN MCF-7 BREAST-CANCER CELLS. In MOLECULAR BIOLOGY OF THE CELL Vol. 3 (pp. A175). AMER SOC CELL BIOLOGY. 1986 VANDYKE, C., VANDYKE, K., CATERSON, B., SZUSTKIEWICZ, C., & REICH, A. (1986). ENHANCED-DURATION-CHEMILUMINESCENCE-IMMUNOASSAY (EDLIA) USING HORSE RADISH PEROXIDASE-LUMINOL-HYDROGEN PEROXIDE-PARA IODOPHENOL (PIP) - CONFIRMATION AND EXTENSION OF THE SYSTEM. In FEDERATION PROCEEDINGS Vol. 45 (pp. 732). FEDERATION AMER SOC EXP BIOL. 1985 THORNTON, M., VANDYKE, K., VANDYKE, C., & DIBARTOLOMEO, A. (1985). SENSITIVITY DIFFERENCES OF PLATELET ACTIVATING FACTOR (PAF) AND LYSO PAF ON CHEMI-LUMINESCENCE (CL) BETWEEN GRANULOCYTES OF NORMAL AND ARTHRITIC PATIENTS. In FEDERATION PROCEEDINGS Vol. 44 (pp. 1839). FEDERATION AMER SOC EXP BIOL.
WoS11984 PEDEN, D., VANDYKE, K., & EDINBORO, L. (1984). THE DISCONJUGATE INHIBITION OF N-FORMYL-METHIONYL-LEUCINYL-PHENYLALANINE INDUCED NEUTROPHIL CHEMI-LUMINESCENCE AND AGGREGATION BY NORDIHYDROGUIARETIC ACID AND INDOMETHACIN. In FEDERATION PROCEEDINGS Vol. 43 (pp. 953). FEDERATION AMER SOC EXP BIOL. 1984 EDINBORO, L., VANDYKE, K., & CASTRANOVA, V. (1984). EFFECTS OF PLATELET ACTIVATING FACTOR ON MEMBRANE-POTENTIAL AND RESPIRATORY BURST ACTIVITY OF HUMAN-GRANULOCYTES. In FEDERATION PROCEEDINGS Vol. 43 (pp. 461). FEDERATION AMER SOC EXP BIOL.
WoS21983 VANDYKE, K., CASTRANOVA, V., & VANDYKE, C. J. (1983). ANTI-INFLAMMATORY DRUG EFFECTS ON LUMINOL-DEPENDENT CHEMI-LUMINESCENCE (CL) FROM HUMAN-GRANULOCYTES STIMULATED BY CA++ IONOPHORE (A23187) AND BY THE REDUCED OR OXIDIZED FORMS OF A FORMYL PEPTIDE (FMLP OR FMOXLP). In FEDERATION PROCEEDINGS Vol. 42 (pp. 698). FEDERATION AMER SOC EXP BIOL.
WoS11982 VANDYKE, K., ENGLISH, D., PEKOE, G., PEDEN, D., MENGOLI, H., & CASTRANOVA, V. (1982). MULTIPURPOSE RADIOMATIC AUTOMATED FLOW LIQUID SCINTILLATION-COUNTER SYSTEM FOR MEASUREMENT OF BURST OR DELAYED CHEMI-LUMINESCENCE REACTIONS - MODEL-DRUG INHIBITION WITH LUMINOL DEPENDENT MYELOPEROXIDASE REACTION. In FEDERATION PROCEEDINGS Vol. 41 (pp. 1549). FEDERATION AMER SOC EXP BIOL. 1982 PEKOE, G. M., PEDEN, D., & VANDYKE, K. (1982). ANTIOXIDANT EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AGAINST PMN MYELOPEROXIDASE INFLAMMATORY FREE-RADICALS MEASURED BY LUMINOL-ENHANCED CHEMI-LUMINESCENCE (CL). In FEDERATION PROCEEDINGS Vol. 41 (pp. 1549). FEDERATION AMER SOC EXP BIOL. 1981 VANDYKE, K. (1981). DETERMINATION OF WATER HARDNESS RESIDUES ON CLOTHS AFTER TERG-O-TOMETER TESTING. In JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY Vol. 58 (pp. A591). AMER OIL CHEMISTS SOC. 1981 CASTRANOVA, V., JONES, G. S., PHILLIPS, R. M., PEDEN, D., & VANDYKE, K. (1981). ABNORMALITIES ASSOCIATED WITH CHRONIC GRANULOMATOUS-DISEASE. In FEDERATION PROCEEDINGS Vol. 40 (pp. 753). FEDERATION AMER SOC EXP BIOL.
WoS11980 JONES, G. S., WILSON, M. E., VANDYKE, K., & CASTRANOVA, V. (1980). DETERMINATION OF TRANSMEMBRANE POTENTIAL IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES. In FEDERATION PROCEEDINGS Vol. 39 (pp. 2100). FEDERATION AMER SOC EXP BIOL. 1979 UDEINYA, I. J., & VANDYKE, K. (1979). INHIBITION OF PARASITIZATION AND MEMBRANE GLYCOPROTEIN SYNTHESIS IN PLASMODIUM-FALCIPARUM BY TUNICAMYCIN AND 2-DEOXYGLUCOSE. In FEDERATION PROCEEDINGS Vol. 38 (pp. 543). FEDERATION AMER SOC EXP BIOL.
WoS11979 VANDYKE, K., UDEINYA, J., VANDYKE, C., BRISTER, C., & WILSON, M. (1979). LUMINOL-DEPENDENT CHEMI-LUMINESCENCE ANALYSIS (LDCA) OF HUMAN NEUTROPHILS - EFFECT OF ANTI-INFLAMMATORY DRUGS AND ENVIRONMENTAL-POLLUTANTS. In FEDERATION PROCEEDINGS Vol. 38 (pp. 441). FEDERATION AMER SOC EXP BIOL. 1978 WILSON, M. E., TRUSH, M. A., SCHREIBER, R. D., & VANDYKE, K. (1978). LUMINOL-DEPENDENT CHEMILUMINESCENCE ANALYSIS (LDCA) OF ALTERNATIVE PATHWAY DEFECTS IN PREMATURE HUMAN NEONATES. In FEDERATION PROCEEDINGS Vol. 37 (pp. 710). FEDERATION AMER SOC EXP BIOL. 1978 UDEINYA, I. J., & VANDYKE, K. (1978). BLOCKADE BY PURINE-6 SULFONIC-ACID 3N OXIDE OF UPTAKE, PHOSPHORYLATION AND POLYMERIZATION OF HYPOXANTHINE-H-3 BY MALARIA PARASITES. In FEDERATION PROCEEDINGS Vol. 37 (pp. 605). FEDERATION AMER SOC EXP BIOL. 1977 TRUSH, M., VANDYKE, K., ROBINSON, R., URQUILLA, P., SMITH, D., TAYLOR, M., . . . CRAIG, C. R. (1977). EVIDENCE THAT MOST OF CATECHOLAMINES IN CHROMAFFIN GRANULES ARE STORED WITHOUT ASSOCIATED ATP. In FEDERATION PROCEEDINGS Vol. 36 (pp. 383). FEDERATION AMER SOC EXP BIOL. 1977 URQUILLA, P. R., VANDYKE, K., & TRUSH, M. (1977). CONTRACTILE EFFECTS OF PYRIMIDINE NUCLEOTIDES IN CANINE CEREBRAL-ARTERIES. In FEDERATION PROCEEDINGS Vol. 36 (pp. 1035). FEDERATION AMER SOC EXP BIOL.
WoS61977 WILSON, M., TRUSH, M., & VANDYKE, K. (1977). EFFECT OF IONOPHORE A23187 ON CHEMILUMINESCENCE BY HUMAN GRANULOCYTES. In FEDERATION PROCEEDINGS Vol. 36 (pp. 1071). FEDERATION AMER SOC EXP BIOL.
WoS51976 VANDYKE, K., CARTER, G., TRUSH, M., & MAWHINNEY, M. G. (1976). INHIBITORY EFFECT OF 2 DEOXYGLUCOSE AND 5-THIO-D-GLUCOSE ON PHOSPHORYLATION OF ADENOSINE-H-3 AND INCORPORATION INTO NUCLEIC-ACIDS OF MALARIAL PARASITES. In FEDERATION PROCEEDINGS Vol. 35 (pp. 749). FEDERATION AMER SOC EXP BIOL. 1976 TRUSH, M. A., VANDYKE, K., & RAMANAN, S. (1976). INHIBITION OF PHAGOCYTOSIS-LINKED LIGHT-EMISSION FROM HUMAN GRANULOCYTES BY PROMETHAZINE - EXAMPLE OF PHOTOPHARMACOLOGY. In FEDERATION PROCEEDINGS Vol. 35 (pp. 748). FEDERATION AMER SOC EXP BIOL.
WoS11976 URQUILLA, P. R., VANDYKE, K., & ROBINSON, R. (1976). RELAXANT EFFECTS OF ADENINE NUCLEOSIDES AND NUCLEOTIDES ON CANINE CEREBRAL-ARTERIES. In FEDERATION PROCEEDINGS Vol. 35 (pp. 699). FEDERATION AMER SOC EXP BIOL.
WoS31975 VANDYKE, K., & NEWCOMER, C. (1975). EFFECT OF PURINE ANTIMETABOLITES ON PHOSPHORYLATION OF HYPOXANTHINE-H-3 IN ERYTHROCYTE-FREE MALARIAL PARASITES. In FEDERATION PROCEEDINGS Vol. 34 (pp. 807). FEDERATION AMER SOC EXP BIOL.
WoS11975 ROWE, J. N., VANDYKE, K., WESTFALL, D. P., & STITZEL, R. E. (1975). INVITRO SYNTHESIS OF ATP IN GUINEA-PIG VAS-DEFERENS. In FEDERATION PROCEEDINGS Vol. 34 (pp. 739). FEDERATION AMER SOC EXP BIOL.
WoS21974 MANANDHA, M. S., & VANDYKE, K. (1974). PURINE-SALVAGE METABOLISM IN FREE MALARIAL PARASITES. In FEDERATION PROCEEDINGS Vol. 33 (pp. 592). FEDERATION AMER SOC EXP BIOL.
WoS41974 VANDYKE, K., & MANANDHA, M. S. (1974). ULTRASENSITIVE DELAYED LUMINESCENCE ANALYSIS (DLA) FOR ALL NATURALLY OCCURRING NUCLEOTIDE TRIPHOSPHATES. In FEDERATION PROCEEDINGS Vol. 33 (pp. 480). FEDERATION AMER SOC EXP BIOL. 1974 MANANDHA, M. S., VANDYKE, K., & ROBINSON, R. L. (1974). METABOLISM OF GUANOSINE-H-3 IN PERFUSED HEART. In FEDERATION PROCEEDINGS Vol. 33 (pp. 385). FEDERATION AMER SOC EXP BIOL. 1973 VANDYKE, K., & CARTER, G. W. (1973). POSSIBLE NEW ROLE FOR ADRENAL-MEDULLA - READY SUPPLY OF PURINES FOR HEART AND LUNGS. In FEDERATION PROCEEDINGS Vol. 32 (pp. 740-&). FEDERATION AMER SOC EXP BIOL.
WoS21972 STEVENS, P., STITZEL, R. E., VANDYKE, K., & ROBINSON, R. L. (1972). SPECIES DIFFERENCE IN DEMONSTRATION OF NUCLEOTIDE LABELING OF CATECHOLAMINE-ATP COMPLEX IN CHROMAFFIN GRANULES OF ADRENAL-MEDULLA. In FEDERATION PROCEEDINGS Vol. 31 (pp. A521-&). FEDERATION AMER SOC EXP BIOL. 1971 VANDYKE, K., STEVENS, P., & ROBINSON, R. L. (1971). DEMONSTRATION OF DYNAMIC NATURE OF ATP IN CATECHOLAMINE-ATP COMPLEX OF ADRENAL GLAND. In FEDERATION PROCEEDINGS Vol. 30 (pp. A445-&). FEDERATION AMER SOC EXP BIOL. 1970 LANTZ, C., & VANDYKE, K. (1970). SELECTIVE EFFECT OF INTERCALATING DRUGS ON ACTIVITY OF RNA POLYMERASE OF MALARIAL PARASITES. In FEDERATION PROCEEDINGS Vol. 29 (pp. A808-+). FEDERATION AMER SOC EXP BIOL.
WoS11969 VANDYKE, K., MCCARTHY, J., FURNER, R., & STITZEL, R. (1969). PATHOLOGICAL EFFECTS OF MALARIA INFECTION ON HOST MICROSOMAL DRUG-METABOLIZING ENZYMES. In FEDERATION PROCEEDINGS Vol. 28 (pp. 366-&). FEDERATION AMER SOC EXP BIOL.
WoS11969 BERGHEI, P., VANDYKE, K., MCCLELLA, T., SZUSTKIE, C., & LANTZ, C. (1969). INHIBITORY EFFECTS OF ANTIMETABOLITES AND INTERCALATING ANTIBIOTICS ON INCORPORATION OF ADENOSINE-8-3HINTO NUCLEIC ACIDS OF MALARIAL PARASITE. In FEDERATION PROCEEDINGS Vol. 28 (pp. 361-&). FEDERATION AMER SOC EXP BIOL. 1968 VANDYKE, K., STITZEL, R., MCCLELLA, T., & SZUSTKIE, C. (1968). A SENSITIVE AND SPECIFIC DETERMINATION OF ATP BY AN AUTOMATED METHOD. In FEDERATION PROCEEDINGS Vol. 27 (pp. 841-&). FEDERATION AMER SOC EXP BIOL. 1968 VANDYKE, K., TREMBLAY, G. C., SZUSTKIE, C., & SAXE, L. H. (1968). PRELIMINARY STUDIES OF PURINE AND PYRIMIDINE INCORPORATION AND BIOSYNTHESIS INTO NUCLEIC ACIDS OF RAT BLOOD PARASITIZED BY PLASMODIUM BERGHEI. In JOURNAL OF PROTOZOOLOGY Vol. S 15 (pp. 23-&). SOC PROTOZOOLOGISTS.
WoS201967 DAVIS, S., & VANDYKE, K. (1967). EFFECT OF PROSCILLARIDIN IN COMBATTING SIMULATED CONGESTIVE HEART FAILURE AND DISAPPEARANCE OF TRITIATED DRUG FROM SEVERAL TISSUES. In FEDERATION PROCEEDINGS Vol. 26 (pp. 782-&). FEDERATION AMER SOC EXP BIOL. 1967 VANDYKE, K., & SZUSTKIE, C. (1967). A SENSITIVE AND SPECIFIC DETERMINATION OF SOME L-ALPHA AMINO ACIDS BY AN AUTOMATED METHOD. In FEDERATION PROCEEDINGS Vol. 26 (pp. 469-&). FEDERATION AMER SOC EXP BIOL. 1966 VANDYKE, K., & KATZMAN, P. A. (1966). EFFECT OF PMS ON ACTIVITY OF RNA POLYMERASE AND SYNTHESIS OF NUCLEIC ACIDS IN OVARIES OF IMMATURE RATS. In FEDERATION PROCEEDINGS Vol. 25 (pp. 286-&). FEDERATION AMER SOC EXP BIOL.
WoS1 -
Conference Items
| Date | Role | Grant | Funding Body | Amount |
|---|---|---|---|---|
| 2024-2027 | CIA | Cancer Australia Priority-driven Collaborative Cancer Research Scheme Project Grant | Cancer Australia | AUD$595,467 |
| 2024-2028 | CIA | NHMRC Ideas Grant | NHMRC | AUD$1,494,105 |
| 2023-2026 | CoI | SSMF Starting Grant | Svenska Sällskapet för Medicinsk Forskning | AUD$869,836 |
| 2021-2023 | CIA | Cancer Australia Priority-driven Young Investigator Grant | Cancer Australia/Cure Cancer Australia/Snowdome Foundation | AUD$198,813 |
| 2019-2022 | CoI | Strategic Ecosystem Research Partnerships | Leukaemia Foundation | AUD$596,198 |
| 2019 - 2021 | CIA | Cancer Australia Priority-driven Young Investigator Grant | Cancer Australia/Cure Cancer Australia/Leukaemia Foundation | AUD$198,596 |
| 2017-2018 | CIA | Cancer Australia Priority-driven Young Investigator Grant | Cure Cancer Australia | AUD$199,454 |
| 2016 | CIA | Project Grant | Royal Adelaide Hospital Contributing Haematologists' Committee | AUD$25,000 |
| 2016 | CIE | Project Grant | Royal Adelaide Hospital Research Fund | AUD$50,000 |
| Date | Title | Funding Body | Amount |
|---|---|---|---|
| 2018-2021 | Beat Cancer Early Career Cancer Research Fellowship | Cancer Council SA | AUD$240,000 |
| 2013-2015 | Mary Overton Early Career Fellowship | Royal Adelaide Hospital | AUD$252,000 |
| 2013-2015 | Veronika Sacco Early Career Fellowship | Florey Medical Research Foundation | AUD$222,003 |
| 2011 | MMRF Research Fellow Award | Multiple Myeloma Research Foundation (USA) | AUD$74,146 |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2025 Co-Supervisor Development and optimisation of tumour vasculature modifying agents to improve drug delivery and enhance treatment outcomes in myeloma Doctor of Philosophy Doctorate Full Time Miss Teena Elise Siapkas 2024 Principal Supervisor Modulating the blood-brain barrier to optimise drug delivery and treatment outcomes in diffuse midline gliomas (DMG) Doctor of Philosophy Doctorate Full Time Miss Tace Sian Conlin 2024 Co-Supervisor Genetic and biochemical characterisation of the SIK3 mutation, R393H: A causal mutation that helps define a new family of human monogenetic disorders Doctor of Philosophy Doctorate Full Time Eliana Gloria Stanziano 2022 Co-Supervisor Lipidomic and metabolomic profiling of the bone marrow microenvironment to understand multiple myeloma disease development Doctor of Philosophy Doctorate Part Time Miss Mackenzie Rose Skinner 2020 Principal Supervisor Changes in the bone marrow microenvironment with progression to multiple myeloma Doctor of Philosophy Doctorate Part Time Miss Laura Joy Trainor -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2020 - 2025 Co-Supervisor Identification of novel genes involved in multiple myeloma tumorigenesis Doctor of Philosophy Doctorate Full Time Miss Hayley Bridget Parkinson 2019 - 2023 Co-Supervisor The Role of Bone Marrow Mesenchymal Stromal Cell Senescence in Multiple Myeloma Doctor of Philosophy Doctorate Full Time Miss Natalya Plakhova 2019 - 2021 Co-Supervisor Macrophages, Myeloma, Mouse Models and Methodologies Doctor of Philosophy Doctorate Full Time Mrs Khatora Shanae Opperman 2017 - 2020 Principal Supervisor CCR1 as a Therapeutic Target in Multiple Myeloma: Preventing Tumour Dissemination and Therapeutic Resistance Doctor of Philosophy Doctorate Full Time Miss Mara Natasha Zeissig 2013 - 2017 Co-Supervisor The Role of TWIST1 in Multiple Myeloma Doctor of Philosophy Doctorate Full Time Miss Chee Man Cheong 2012 - 2018 Co-Supervisor N-cadherin: Regulation, Role and Therapeutic Targeting in Multiple Myeloma Doctor of Philosophy Doctorate Full Time Mr Krzysztof Mrozik
-
Committee Memberships
Date Role Committee Institution Country 2024 - ongoing Member South Australian Cancer Research Biobank (SACRB) Strategy & Governance Committee South Australian Cancer Research Biobank Australia 2023 - ongoing Member Myeloma Australia Myeloma Scientific Advisory Group (MSAG) Research Pillars Committee Myeloma Australia Australia 2015 - ongoing Member Women's and Children's Hospital Foundation Research Grants Committee - - 2014 - ongoing Member Australian Society for Medical Research SA Committee - - -
Memberships
Date Role Membership Country 2021 - ongoing Member International Myeloma Society United States 2019 - ongoing Member Australasian Leukaemia and Lymphoma Group Australia 2015 - ongoing - Haematology Society of Australia and New Zealand - 2014 - ongoing Member Australian Society for Medical Research - -
Editorial Boards
Date Role Editorial Board Name Institution Country 2022 - ongoing Associate Editor Frontiers in Oncology Editorial Board Frontiers Switzerland 2020 - ongoing Associate Editor Journal of Bone Oncology Editorial Board Elsevier Germany 2020 - ongoing Associate Editor BMC Cancer Editorial Board BMC United Kingdom
Connect With Me
External Profiles
